Loading...

⚠ โœ•
❮ Top
☎ Help
Draft upto 3 replies to a
tax notice โ€” FREE ๐ŸŽ‰ โœ•

150 credits ยท 30 days

โ€ข Basic Search โ†’ 1 Credit
โ€ข Advanced Search โ†’ 3 Credits
โ€ข Drafter โ†’ 20 to extract + 25 per issue
(โ‰ˆ upto 2-3 drafts on us)

Already used our earlier 20-Credit Demo?
You are still eligible for this new 150-Credit Demo.

Activate your FREE Demo โ†’
☰
×

By creating an account you can:

Logo TaxTMI
Call Us / Help / Feedbackโœ•

Contact Us At :

✉ E-mail: [email protected]

✆ Call / WhatsApp at: +91 99117 96707

For more information, Check Contact Us

FAQs :

To know Frequently Asked Questions, Check FAQs

Most Asked Video Tutorials :

For more tutorials, Check Video Tutorials

Submit Feedback/Suggestion :

Email :
Please provide your email address so we can follow up on your feedback.
Category :
Description :
Min 15 characters 0/2000
TMI Blog
Home / TMI Blogs / RSS

1999 (2) TMI 150

X X   X X   Extracts   X X   X X

Full Text of the Document

X X   X X   Extracts   X X   X X

....dents. [Order per : S.S. Kang, Member (J)]. - Revenue filed this appeal against the order-in-appeal dated 6-10-1994 passed by the Collector of Central Excise (A), Pune. In the impugned order the ld. Collector held that tablets manufactured by the respondents are classifiable under sub-heading 3003.20 of the Central Excise Tariff. 2. When the case was called, none appeared on behalf of res....

X X   X X   Extracts   X X   X X

Full Text of the Document

X X   X X   Extracts   X X   X X

.... Central Excise Tariff and not under Chapter Heading 3003.20 as claimed by the respondents. The adjudicating authority approved the classification list as claimed by the respondents. The Revenue filed the appeal before the Collector (A) and the same was dismissed. In this case the product in question is Ferrous Gluconate Tablets which are mentioned in the U.S. Pharmacopoeia. The Revenue has not pr....